Mission BioCapital
missionbiocapital.com Direct investor
Mission BioCapital is a venture capital firm that provides early-stage capital to life science entrepreneurs. It also operates shared lab spaces and offers support services through its Platinum Program.
Mission BioCapital is a venture capital firm headquartered in Cambridge, United States, founded in 2009. It invests directly in companies, from seed to Series A, in life sciences, biotechnology, therapeutics and diagnostics. 50 portfolio companies, as it reports.
“At Mission BioCapital, we provide early-stage capital to the next generation of awesome life science entrepreneurs and the platform where they can realize their visions.”
— Mission BioCapital, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Cambridge, United States
- Invests in
- US, Europe
- Sectors
- life sciences, biotechnology, therapeutics, diagnostics, lab tools, devices, drug delivery, agriculture and climate
- Founded
- 2009
- Portfolio
- 50 companies
Team, as Mission BioCapital publishes it
- Robert Blazej Partner
- Cassidy Blundell Partner
- Josephine Brysting Investment Analyst
- Mark Byrnes Director of Operations, Cambridge
- Chris Carlin Chief Operations Officer and Chief Compliance Officer
- Zach Collins Partner
- Douglas Crawford Managing General Partner
- Linda Eng Director of Operations, Bay Area
- Johannes Fruehauf General Partner
- Jennifer Griffin Partner
- Samar Jahan Vice President of Finance
- Ulrik B. Nielsen General Partner
Names and roles exactly as listed on missionbiocapital.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 68 co-investors found.
- Mission Bay Capital 20 shared companies: cariboubio.com, mammoth.bio, drenbio.com, epiodyne.com…
- INKEF Capital 2 shared companies: ambagontx.com, quralis.com
- Dolby Family Capital Management LLC 2 shared companies: quralis.com, progentos.com
- Mitsui & Co. Global Investment, Inc. 2 shared companies: quralis.com, symic.bio
- Leaps by Bayer 2 shared companies: nuvigtherapeutics.com, sound.ag
- Gimv 2 shared companies: immunostherapeutics.com, mediartx.com
- 8VC 2 shared companies: mammoth.bio, drenbio.com
- Decheng Capital 2 shared companies: mammoth.bio, shapetx.com
- Aisling Capital Management LP 2 shared companies: drenbio.com, atreca.com
- RA Capital Management 2 shared companies: asherbio.com, vivacetherapeutics.com
and 58 more — the graph.
Where this comes from
Every fact above was read from a page Mission BioCapital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.missionbiocapital.com/name, is_investor, layer, type, hq_country, hq_city, stage_min, stage_max, thesis_quote, thesis_quote_page, description, founded, status
- https://www.missionbiocapital.com/team/invests_in_geographies, people
- https://www.missionbiocapital.com/portfolio/sectors, portfolio_count
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 2935 · added 2026-09-03 · link last verified 2026-09-06 · confidence high
Similar investors
- Atlas VentureVenture capital · Seed – Series A · Cambridge, United States
- Iaso VenturesVenture capital · Cambridge, United States
- RA Capital ManagementVenture capital · Pre-seed – Growth · Boston, United States
- Altitude Life Science VenturesVenture capital · Seed – Series A · United States
- Avalon BioVentures Management, LLCVenture capital · Seed – Series A · San Diego, United States
- Cure Ventures Management, LPVenture capital · Seed – Series A · Boston, United States